Metraipolis › archive › dc_28aa121abf65
CircPPFIA2 drives prostate cancer progression and enzalutamide resistance by sponging miR-646 and miR-1200 to upregulate ETS1 — Europe PMC PMID:41360764
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41360764
- DOI
- 10.1038/s41420-[numero omesso]-z
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-07T20:00:17.684Z
- SHA-256 of the archived text
5aa4a3eb553efd5cd4223caa299ad8fe29fe9453c1f2ddce5de56eeb9fb8116f- Stable URL of this page
https://metraipolis.com/documento/dc_28aa121abf65
How to cite
CircPPFIA2 drives prostate cancer progression and enzalutamide resistance by sponging miR-646 and miR-1200 to upregulate ETS1 — Europe PMC PMID:41360764 — Europe PMC (en), https://europepmc.org/article/MED/41360764 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_28aa121abf65 (Metraipolis archive dc_28aa121abf65, sha256 5aa4a3eb553efd5cd4223caa299ad8fe29fe9453c1f2ddce5de56eeb9fb8116f)
BibTeX
@misc{dc28aa121abf65,
title = {CircPPFIA2 drives prostate cancer progression and enzalutamide resistance by sponging miR-646 and miR-1200 to upregulate ETS1 — Europe PMC PMID:41360764},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41360764},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_28aa121abf65; sha256 5aa4a3eb553efd5cd4223caa299ad8fe29fe9453c1f2ddce5de56eeb9fb8116f},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41360764. Agents can read the archived copy with the MCP tool read_document.